1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Unilever PLC
  6. News
  7. Summary
    ULVR   GB00B10RZP78

UNILEVER PLC

(ULVR)
  Report
Delayed London Stock Exchange  -  05/27 11:39:44 am EDT
3475.50 GBX   -0.36%
05/27Unilever supply chain in Gartner 'Masters' category fourth year running
AQ
05/27Fitch Affirms Unilever at 'A'; Stable Outlook
AQ
05/26Fitch Maintains Unilever's Ratings on Expected Profit Recovery in FY23
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Unilever ADRs Drop After Approach for Glaxo's Consumer-Health Business

01/18/2022 | 10:41am EDT

By Robb M. Stewart


Unilever PLC's U.S.-listed stock retreated Tuesday as investors reacted to the company's efforts to push further into health, beauty and hygiene products with a $68 billion approach for GlaxoSmithKline PLC's consumer-health business.

In morning trading, the American depositary receipts were 11% lower at $48.41. They now stand down 10% in the new year, and 19% weaker over the last 12 months.

The maker of Dove soap and Ben & Jerry's ice cream over the weekend said it made a takeover approach for the business, which is 68% owned by Glaxo and 32% by Pfizer Inc. If successful, it would be Unilever's biggest-ever acquisition and the company said it would be accompanied by significant divestitures as it looks to shift its portfolio toward higher-growth categories.

Fitch Ratings on Tuesday cautioned an acquisition of the consumer-health business is likely to raise Unilever's debt to a level the company wouldn't be able to reduce it sufficiently to maintain an A rating category over 2024-2025, which could open the door to a multi-notch downgrade into the BBB category. Fitch said it believes Unilever's offer would need to be raised to be successful, given Glaxo's refusal to consider it, resulting in a further deterioration of the company's expected credit metrics.


Write to Robb M. Stewart at robb.stewart@wsj.com


(END) Dow Jones Newswires

01-18-22 1041ET

Stocks mentioned in the article
ChangeLast1st jan.
GSK PLC -1.17% 1733.2 Delayed Quote.7.88%
PFIZER, INC. -0.15% 53.91 Delayed Quote.-8.70%
UNILEVER PLC -0.36% 3475.5 Delayed Quote.-11.91%
All news about UNILEVER PLC
05/27Unilever supply chain in Gartner 'Masters' category fourth year running
AQ
05/27Fitch Affirms Unilever at 'A'; Stable Outlook
AQ
05/26Fitch Maintains Unilever's Ratings on Expected Profit Recovery in FY23
MT
05/25Nestlé Said To Have Explored Possible Purchase Of GSK's Consumer Health Unit
MT
05/24Global energy and funding shocks test climate commitments
RE
05/23Indian Benchmarks End Marginally Lower; JSW Steel Slumps 13%
MT
05/20Inflation crimps Indian firms as rural millions cut spending
RE
05/19European ADRs Move Higher in Thursday Trading
MT
05/19London's FTSE 100 tumbles on global slowdown worries
RE
05/19European shares lower as retailers, food and beverage stocks lead falls
RE
More news
Analyst Recommendations on UNILEVER PLC
More recommendations
Financials
Sales 2022 57 621 M 61 732 M 61 732 M
Net income 2022 5 639 M 6 041 M 6 041 M
Net Debt 2022 23 916 M 25 623 M 25 623 M
P/E ratio 2022 19,5x
Yield 2022 4,16%
Capitalization 104 B 112 B 112 B
EV / Sales 2022 2,23x
EV / Sales 2023 2,14x
Nbr of Employees 148 012
Free-Float 95,5%
Chart UNILEVER PLC
Duration : Period :
Unilever PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends UNILEVER PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 40,92 €
Average target price 47,14 €
Spread / Average Target 15,2%
EPS Revisions
Managers and Directors
Alan Jope Chief Executive Officer & Executive Director
Graeme David Pitkethly Chief Financial Officer & Executive Director
Nils Smedegaard Andersen Chairman
Richard Slater Chief Research & Development Officer
Nitin Paranjpe Chief Operating, Transformation & People Officer
Sector and Competitors
1st jan.Capi. (M$)
UNILEVER PLC-11.91%111 745
PROCTER & GAMBLE COMPANY-9.08%356 823
THE ESTÉE LAUDER COMPANIES INC.-35.06%90 001
HINDUSTAN UNILEVER LIMITED-1.25%70 581
COLGATE-PALMOLIVE COMPANY-7.59%66 080
RECKITT BENCKISER GROUP PLC-3.53%55 187